Click Holdings Limited (NASDAQ:CLIK) Short Interest Down 29.1% in December

Click Holdings Limited (NASDAQ:CLIK) saw a large drop in short interest during the month of December. As of December 15th, there was short interest totaling 9,893 shares, a drop of 29.1% from the November 30th total of 13,952 shares. Based on an average daily volume of 89,670 shares, the short-interest ratio is presently 0.1 days. Approximately 0.9% of the shares of the stock are sold short. Approximately 0.9% of the shares of the stock are sold short. Based on an average daily volume of 89,670 shares, the short-interest ratio is presently 0.1 days.

Click Stock Performance

Shares of CLIK stock opened at $5.63 on Monday. Click has a twelve month low of $4.80 and a twelve month high of $102.90. The stock’s fifty day simple moving average is $6.46 and its 200 day simple moving average is $9.09.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reissued a “sell (d)” rating on shares of Click in a research note on Monday, December 22nd. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the company has an average rating of “Sell”.

About Click

Click Therapeutics, Inc (NASDAQ: CLIK) is a clinical-stage digital therapeutics company developing software-based treatments for neurological, psychiatric and chronic diseases. Its platform delivers prescription digital therapies via mobile and web applications, combining evidence-based cognitive behavioral interventions, digital monitoring tools and patient engagement techniques. Click’s approach is designed to complement or extend traditional pharmacological and behavioral treatments for conditions such as major depressive disorder, insomnia and tobacco use disorder.

Founded in 2014, Click has progressed multiple programs through randomized controlled trials and regulatory review.